Compare Stocks

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVDL Avadel Pharmaceuticals		$15.31	$9.50 ▼ $18.01	$1.54B	1.6	1.22 million shs	2.41 million shs
CNCE Concert Pharmaceuticals	$8.37	$8.37	$2.66 ▼ $8.55	$401.26M	0.52	2.97 million shs	N/A
LCI Lannett		$1.54	$0.64 ▼ $3.72	$7.38M	0.95	92,067 shs	280,600 shs
OGI Organigram	$1.88 -3.1%	$2.11	$0.97 ▼ $2.91	$200.22M	1.09	2.38 million shs	2.16 million shs
OSMT Osmotica Pharmaceuticals		$1.16	$0.98 ▼ $4.95	$69.47M	2.34	396,682 shs	296,500 shs

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVDL Avadel Pharmaceuticals	0.00%	-6.65%	+0.44%	+7.46%	+61.35%
CNCE Concert Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
LCI Lannett	0.00%	0.00%	0.00%	0.00%	-0.65%
OGI Organigram	-3.09%	-13.76%	-9.18%	-1.05%	-15.32%
OSMT Osmotica Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVDL Avadel Pharmaceuticals	3.4157 of 5 stars	4.5	2.0	0.0	0.0	2.6	3.3	0.6
CNCE Concert Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LCI Lannett	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OGI Organigram	0.365 of 5 stars	0.0	2.0	0.0	0.0	3.2	0.0	1.3
OSMT Osmotica Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVDL Avadel Pharmaceuticals	3.00	Buy	$22.57	∞ Upside
CNCE Concert Pharmaceuticals	N/A	N/A	N/A	N/A
LCI Lannett	N/A	N/A	N/A	N/A
OGI Organigram	3.00	Buy	N/A	N/A
OSMT Osmotica Pharmaceuticals	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest AVDL, OSMT, CNCE, OGI, and LCI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/15/2024	OGI Organigram	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy
4/9/2024	AVDL Avadel Pharmaceuticals	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$22.00
3/5/2024	AVDL Avadel Pharmaceuticals	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $22.00
3/5/2024	AVDL Avadel Pharmaceuticals	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$18.00 ➝ $23.00
3/5/2024	AVDL Avadel Pharmaceuticals	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$27.00 ➝ $29.00
3/5/2024	AVDL Avadel Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$21.00 ➝ $25.00
3/5/2024	AVDL Avadel Pharmaceuticals	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $22.00
2/6/2024	AVDL Avadel Pharmaceuticals	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$21.00

(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVDL Avadel Pharmaceuticals	$27.96M	0.00	N/A	N/A	$0.98 per share	0.00
CNCE Concert Pharmaceuticals	$32.58M	12.32	N/A	N/A	$3.24 per share	2.58
LCI Lannett	$340.58M	0.00	N/A	N/A	($23.34) per share	0.00
OGI Organigram	$120.01M	1.62	N/A	N/A	$2.48 per share	0.76
OSMT Osmotica Pharmaceuticals	$177.88M	0.00	N/A	1.00	$1.50 per share	0.00

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVDL Avadel Pharmaceuticals	-$160.28M	-$2.04	N/A	0.00	N/A	N/A	-198.06%	-84.51%	5/2/2024 (Estimated)
CNCE Concert Pharmaceuticals	-$80.05M	-$3.21	N/A	N/A	N/A	N/A	-109.43%	-76.65%	N/A
LCI Lannett	-$231.62M	-$18.88	N/A	N/A	N/A	-62.40%	N/A	-13.39%	N/A
OGI Organigram	-$184.34M	-$0.80	N/A	N/A	N/A	-173.48%	-30.94%	-27.70%	4/16/2024 (Estimated)
OSMT Osmotica Pharmaceuticals	-$79.59M	-$1.59	N/A	N/A	N/A	-138.76%	-81.23%	-20.97%	N/A

Latest AVDL, OSMT, CNCE, OGI, and LCI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/4/2024	Q4 2023	AVDL Avadel Pharmaceuticals	-$0.28	-$0.32	-$0.04	-$0.29	$17.41 million	$19.45 million
2/13/2024	Q1 2024	OGI Organigram	-$0.10	-$0.14	-$0.04	-$0.14	$28.61 million	$26.78 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVDL Avadel Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
CNCE Concert Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
LCI Lannett	N/A	N/A	N/A	N/A	N/A
OGI Organigram	N/A	N/A	N/A	N/A	N/A
OSMT Osmotica Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVDL Avadel Pharmaceuticals	N/A	3.64	3.36
CNCE Concert Pharmaceuticals	N/A	9.03	9.03
LCI Lannett	N/A	2.23	1.39
OGI Organigram	N/A	4.28	2.11
OSMT Osmotica Pharmaceuticals	N/A	0.43	0.42

Ownership

Institutional Ownership

Company	Institutional Ownership
AVDL Avadel Pharmaceuticals	69.19%
CNCE Concert Pharmaceuticals	70.63%
LCI Lannett	40.28%
OGI Organigram	34.63%
OSMT Osmotica Pharmaceuticals	46.18%

Insider Ownership

Company	Insider Ownership
AVDL Avadel Pharmaceuticals	4.00%
CNCE Concert Pharmaceuticals	11.33%
LCI Lannett	13.12%
OGI Organigram	0.09%
OSMT Osmotica Pharmaceuticals	5.22%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AVDL Avadel Pharmaceuticals	154	90.58 million	86.95 million	Optionable
CNCE Concert Pharmaceuticals	64	47.94 million	42.51 million	Optionable
LCI Lannett	810	10.77 million	9.35 million	Optionable
OGI Organigram	984	103.20 million	103.11 million	Optionable
OSMT Osmotica Pharmaceuticals	302	62.59 million	59.32 million	Not Optionable

AVDL, OSMT, CNCE, OGI, and LCI Headlines

Source	Headline
	Vanda Pharmaceuticals Inc. wsj.com - March 6 at 4:32 PM
	RVL Pharmaceuticals PLC (RVLPQ) investing.com - December 19 at 9:08 AM
	Other OTC Pharmaceuticals - Seychelles statista.com - October 8 at 8:51 PM
	Osmotica Pharmaceuticals is about to announce its earnings — here's what to expect markets.businessinsider.com - August 14 at 1:21 AM
	What Wall Street expects from Osmotica Pharmaceuticals's earnings markets.businessinsider.com - March 19 at 12:43 PM
	GRO Biosciences Appoints Rakhshita Dhar to its Board of Directors nz.finance.yahoo.com - January 19 at 9:21 PM
	UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance finance.yahoo.com - January 19 at 3:55 PM
	Osmotica Pharmaceuticals Announces Corporate Name Change to RVL Pharmaceuticals plc With New Ticker Symbol 'RVLP' benzinga.com - January 19 at 10:54 AM
	Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance finance.yahoo.com - January 19 at 10:54 AM
	RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022 finance.yahoo.com - January 18 at 7:56 AM
	Fresh Insights On Osmotica Pharmaceuticals plc (OSMT) stocksregister.com - January 15 at 6:25 PM
	Osmotica Pharmaceuticals plc (OSMT): What Is Good About Stock? marketingsentinel.com - January 11 at 7:36 AM
	Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022 finance.yahoo.com - January 6 at 9:24 AM
	Boom Or Bust: What Are Osmotica Pharmaceuticals plc’s (NASDAQ:OSMT) Future Prospects? marketingsentinel.com - January 1 at 10:28 AM
	Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Shares Rose Recently. However, Trouble May Still Be Lurking. stocksregister.com - December 27 at 12:57 PM
	Osmotica Pharmaceuticals plc (NASDAQ: OSMT): Why Investors Shouldn’t Ditch OSMT Stock In 2021 marketingsentinel.com - December 27 at 12:57 PM
	Osmotica Pharmaceuticals plc (NASDAQ:OSMT) Shares Plunged 0.00% In A Week – But Will They Keep Going Up? marketingsentinel.com - December 23 at 2:40 PM
	James Schaub Is The Executive VP & COO of Osmotica Pharmaceuticals plc (NASDAQ:OSMT) And They Just Picked Up 30% More Shares nasdaq.com - December 22 at 2:02 PM
	Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference finance.yahoo.com - December 20 at 6:40 PM
	Osmotica Pharmaceuticals plc (NASDAQ: OSMT):The Stock Was Down -2.04 Percent From Its Lows On Friday, So What’s To Come? marketingsentinel.com - December 18 at 6:32 PM
	Osmotica Pharmaceuticals EPS Diluted (5 Year Growth) ycharts.com - December 18 at 12:57 AM
	Osmotica Pharmaceuticals plc (OSMT) Could Be Sitting On A Goldmine stocksregister.com - December 4 at 10:20 AM
	What Analysts Were Expecting After Osmotica Pharmaceuticals plc (NASDAQ: OSMT) rose 2.76% stocksregister.com - November 25 at 2:06 PM
	The Future Of Osmotica Pharmaceuticals plc (NASDAQ: OSMT) In 2021 stocksregister.com - November 18 at 9:51 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024 1:50 PM
View Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
March 27, 2024 7:30 AM
View Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
SoFi Presents Another Entry Opportunity for Investors
March 19, 2024 7:32 AM
View SoFi Presents Another Entry Opportunity for Investors
3 Stocks About to Join the Rate Cut Party
March 21, 2024 7:12 AM
View 3 Stocks About to Join the Rate Cut Party

All Headlines

Company Descriptions

Avadel Pharmaceuticals

NASDAQ:AVDL

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Concert Pharmaceuticals

NASDAQ:CNCE

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.

Lannett

NYSE:LCI

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Organigram

NASDAQ:OGI

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

Osmotica Pharmaceuticals

NASDAQ:OSMT

Osmotica Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, M-72, Arbaclofen ER, OS870, Divigel, OB Complete, Methylphenidate ER, Venlafaxine ER tablets (VERT), Hydromorphone ER, Sodium Benzoate/Sodium Phenylacetate, Oxybutynin ER, Prescription Prenatal Vitamins, Chlorzoxazone (Lorzone AG), Tramadol ER (ConZip AG), Nitrofurantoin and Osmodex ANDAs. The company was founded in 1986 and is headquartered in Bridgewater, NJ.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial